FILE PHOTO: Picture illustration of a UnitedHealth Group health insurance card in a wallet (Reuters) -UnitedHealth's pharmacy benefit manager unit said on Thursday it was adding eight insulin products ...
The average price per insulin unit hit a 10-year low in 2024, largely driven by federal actions and voluntary price cuts from drugmakers, according to a Jan. 15 GoodRx report. GoodRx analyzed the ...
ORLANDO -- Most adults with type 1 diabetes switching from an insulin pump or multiple daily injections to inhaled insulin (Afrezza) needed to increase their dose of the inhaled product to achieve ...
The FDA has approved a label update for an inhaled insulin indicated for adults with type 1 or type 2 diabetes, according to ...
Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: A screen displays the logo for Cigna Corp. on the floor at the NYSE in New York (Reuters) - Cigna Corp's pharmacy ...
The FINANCIAL — Eli Lilly and Company and Boehringer Ingelheim Pharmaceuticals, Inc. announced on December 15 that BASAGLAR (insulin glargine injection 100 units/mL) is available by prescription in ...
InvestorsHub on MSN
MannKind shares climb after FDA clears revised Afrezza prescribing label
MannKind Corporation (NASDAQ:MNKD) shares gained 3.5% on Monday after the company said the U.S. Food and Drug Administration has approved changes to the prescribing information for its Afrezza inhaled ...
Am J Health Syst Pharm. 2005;62(21):2260-2264. Verify that the patient is receiving some source of exogenous glucose before initiating infusion (e.g., total parenteral nutrition [TPN], i.v. fluids ...
Hy-Vee is lending a hand to diabetes patients not covered by Medicare who seek lower-cost insulin. West Des Moines, Iowa-based Hy-Vee said Thursday that it has launched an insulin savings website that ...
Nov 9 (Reuters) - UnitedHealth's UNH.N pharmacy benefit manager unit said on Thursday it was adding eight insulin products to its reimbursement list that would limit out-of-pocket spend to $35 or less ...
The protocol was evaluated for the first 30 patients. Data were collected from September 2003 to August 2004. When a patient was started on the protocol, the pharmacy clinical coordinator and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results